logo
16:01 Feb 03

Novelix Pharmaceuticals Ltd.

Sector Retailing Industry Specialty Retail
Up
62.85
+2.88 (+4.80%)
Sector Retailing Industry Specialty Retail

Novelix Pharmaceuticals Ltd. Financials

Novelix Pharmaceuticals Ltd.
Sector Retailing
Industry Specialty Retail
Up
62.85
+2.88 (+4.80%)
16:01 Feb 03
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

70/100
Technically Moderately Bullish

Strength

13

Weakness

6

Opportunity

0

Threats

0

-24.31 %

ROE %

-20.60 %

ROA %

0.00

EPS

9.48

BVPS

-20.91 %

Net Profit Margin

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales
10.5 10.46 10.24 9.24 8.61
Operating Expenses +
10.51 10.62 10.76 13.04 11.18
Raw Material
5.69 1.54 7.64 7.03 8.53
Increase Decrease in Cost
0.13 0.02 -0.09 -0.03 -0.28
Other Manufacturing Expense
2.94 7.48 1.62 1.56 0.01
Employee Cost
0.99 0.99 0.96 0.99 0.44
Miscellaneous Expenses
9.82 0.59 11.67 13.51 4.66
Operating Profit
-0.01 -0.16 -0.52 -3.8 -2.57
Other Income
0.21 0.38 0.6 0.34 0.55
Depreciation
0.24 0.21 0.19 0.21 0.1
Interest
0.16 0.13 0.11 0.06 0
Profit before tax and exceptio..
-0.2 -0.12 -0.21 -3.73 -2.12
Exceptional Items
0 0 0 0 0
PBT
-0.2 -0.12 -0.21 -3.73 -2.12
Provision for Taxation
0.15 0.02 0.04 0.01 -0.01
Net Profit
-0.35 -0.15 -0.26 -3.74 -2.11
NET Profit after MI
-0.39 -0.24 -0.28 -3.74 -1.8
EPS
-0.48 -0.3 -0.35 -4.62 -2.22
Operating Profit Margin (%)
-0.1 -1.53 -5.08 -41.13 -29.85
Net Profit Margin (%)
-3.71 -2.29 -2.73 -40.48 -20.91

Novelix Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 52.00 53.30 52.80 66.60 66.60 66.60
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 48.00 46.70 47.20 33.40 33.40 33.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: